COX6C is a nuclear-encoded subunit of cytochrome c oxidase (Complex IV), critical for electron transport chain function. The recombinant version from Saimiri sciureus retains full-length structural integrity (75 amino acids) with an N-terminal 10xHis-tag for purification and detection.
The protein is synthesized via bacterial expression systems, optimized for high yield and solubility. Critical parameters include:
Aspect | Detail |
---|---|
Host Organism | E. coli |
Expression Region | Mature protein (residues 2–75) |
Storage Buffer | Tris-based buffer with 50% glycerol (pH 8.0) |
Purity | >90% (SDS-PAGE verified) |
Stability | Stable at -20°C or -80°C; repeated freeze-thaw cycles discouraged |
The recombinant protein serves as a tool for studying mitochondrial function, evolutionary conservation, and disease models.
Application | Method | Purpose |
---|---|---|
ELISA | Antigen-coated plates with specific antibodies | Quantitative analysis of COX6C expression levels |
Western Blot | SDS-PAGE separation, His-tag detection | Confirmation of protein identity and purity |
Antibody Production | Immunization of animals with purified COX6C | Generation of species-specific antibodies for primate studies |
Protein Interaction Studies | Co-immunoprecipitation or pull-down assays | Mapping interactions with other Complex IV subunits (e.g., COX1, COX2) |
While Saimiri sciureus COX6C shares structural homology with human COX6C (e.g., similar His-tag placement), sequence divergence highlights evolutionary adaptation:
Current data on Saimiri sciureus COX6C remain limited to production and structural parameters. Future studies could explore:
Functional roles in primate mitochondrial disorders.
Comparative analysis of COX6C regulatory mechanisms across primates.
Utility in vaccine or therapeutic protein development targeting mitochondrial diseases.
Recombinant Saimiri sciureus Cytochrome c oxidase subunit 6C (COX6C) is a component of cytochrome c oxidase (complex IV, CIV), the terminal enzyme in the mitochondrial electron transport chain. This chain, encompassing succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (complex III, CIII), and CIV, facilitates electron transfer from NADH and succinate to molecular oxygen. This process generates an electrochemical gradient across the inner mitochondrial membrane, driving ATP synthesis. COX6C plays a crucial role in CIV's catalytic function, reducing oxygen to water. Electrons from reduced cytochrome c in the intermembrane space are transferred through the copper A center (CuA) of subunit 2 and heme A of subunit 1 to the binuclear center (BNC) in subunit 1. This BNC, composed of heme A3 and copper B (CuB), reduces molecular oxygen to two water molecules, utilizing four electrons from cytochrome c and four protons from the mitochondrial matrix.
COX6C is a critical component of cytochrome c oxidase (Complex IV), the terminal enzyme in the mitochondrial electron transport chain that drives oxidative phosphorylation. In Saimiri sciureus (squirrel monkey), as in other mammals, this subunit contributes to the structural integrity and functional efficiency of the complex. COX6C belongs to the cytochrome c oxidase subunit 6c family, with a molecular mass of approximately 8.8 kDa . The protein participates in the electron transfer process that catalyzes the reduction of oxygen to water, which creates an electrochemical gradient across the inner mitochondrial membrane to drive ATP synthesis .
While there is high conservation among mammalian COX6C proteins, species-specific variations exist that may affect protein-protein interactions within the complex. Comparative analysis between human and Saimiri sciureus COX6C typically reveals:
Feature | Human COX6C | S. sciureus COX6C | Significance |
---|---|---|---|
Amino acid identity | Reference | >90% estimated | High functional conservation |
Post-translational modifications | Well-characterized | Similar patterns expected | Important for regulation |
3D structure | Determined | Predicted to be similar | Critical for complex assembly |
Researchers should note that these minor variations might influence antibody recognition, protein-protein interactions, and potentially the kinetic properties of the assembled cytochrome c oxidase complex.
COX6C is integral to mitochondrial respiration as part of cytochrome c oxidase. The respiratory chain contains three multisubunit complexes (including complex IV containing COX6C) that cooperate to transfer electrons from NADH and succinate to molecular oxygen . Specifically, electrons from reduced cytochrome c in the intermembrane space are transferred via copper centers and heme groups to the binuclear center where oxygen is reduced to water .
Research indicates that COX6C function impacts:
Recent studies on COX6C knockdown have demonstrated significant impairment of oxidative phosphorylation, with decreased oxygen consumption rate in basal respiration, maximal respiration, and ATP turnover .
Based on similar cytochrome c oxidase subunit expression studies, the most effective systems for producing recombinant COX6C include:
E. coli expression system:
Bacterial expression using vectors such as pET-32a with IPTG induction in E. coli strains like Transetta (DE3) has proven effective for other cytochrome c oxidase subunits . For optimal expression of Saimiri sciureus COX6C:
Clone the full-length cDNA into an expression vector with an appropriate tag (His-tag recommended for purification)
Transform into an E. coli expression strain optimized for membrane and mitochondrial proteins
Induce with IPTG at concentrations between 0.1-1.0 mM
Incubate at lower temperatures (16-25°C) to enhance proper folding
Include protease inhibitors during cell lysis to prevent degradation
Alternative expression systems include yeast (particularly P. pastoris) and mammalian cell lines, which may provide better post-translational modifications but at higher cost and complexity.
Optimal purification of recombinant Saimiri sciureus COX6C typically involves:
Initial purification: Affinity chromatography using Ni²⁺-NTA agarose for His-tagged proteins
Secondary purification: Ion exchange chromatography to remove remaining contaminants
Final polishing: Size exclusion chromatography to separate monomeric protein from aggregates
Key considerations for maintaining activity:
Include mild detergents (0.1-0.5% n-dodecyl β-D-maltoside) throughout purification
Add stabilizing agents (10% glycerol, 1 mM DTT) to all buffers
Maintain pH between 7.0-8.0 and keep samples at 4°C
Avoid freeze-thaw cycles and store aliquots at -80°C
Typical yield from bacterial expression systems ranges from 1-5 mg/L of culture, with purity >95% achievable after complete purification.
Multiple complementary methods should be employed to verify proper folding and functionality:
Structural integrity assessment:
Circular dichroism (CD) spectroscopy to analyze secondary structure
Thermal shift assays to determine protein stability
Limited proteolysis to assess compact folding
Functional verification:
Cytochrome c oxidation assay to measure enzymatic activity, similar to methods used for other COX subunits
Binding assays with other complex IV subunits
Reconstitution experiments with isolated mitochondrial membranes
UV-spectrophotometer and infrared spectrometer analysis can be utilized to monitor the catalytic oxidation of cytochrome c, as demonstrated with other cytochrome c oxidase subunits . Additionally, researchers should verify that the recombinant protein can incorporate properly into mitochondrial complexes using blue native PAGE or sucrose gradient ultracentrifugation.
Recombinant Saimiri sciureus COX6C serves as a valuable tool for investigating mitochondrial dysfunction in various disease models:
Experimental approaches:
Complementation studies: Introduce wild-type or mutant recombinant COX6C into COX6C-depleted cells to assess rescue of phenotypes
Mitochondrial dynamics: Examine changes in mitochondrial fusion and fission using fluorescently tagged mitochondria and recombinant COX6C variants
Respiration analysis: Measure oxygen consumption rates with and without recombinant COX6C to assess its direct impact on respiratory function
ROS generation: Quantify reactive oxygen species production using fluorescent probes in cells with manipulated COX6C levels
Research findings demonstrate that COX6C knockdown results in mitochondrial fragmentation, with mitochondrial length decreasing significantly from normal levels . Electron microscopy can reveal structural changes in mitochondria, while measuring expression of mitochondrial fusion proteins such as mfn1 provides molecular insights into fusion defects .
COX6C forms critical interactions with other subunits of the cytochrome c oxidase complex that can be studied using recombinant proteins:
Key interactions and investigation methods:
Interaction Partner | Method of Study | Expected Outcome |
---|---|---|
Core COX subunits (I, II, III) | Co-immunoprecipitation | Direct binding partners |
Assembly factors | Pull-down assays | Temporal assembly sequence |
Cardiolipin and other lipids | Lipid binding assays | Stabilization requirements |
Cytochrome c | Surface plasmon resonance | Binding kinetics and affinity |
Advanced techniques for interaction mapping:
Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to map interaction surfaces
Chemical cross-linking followed by mass spectrometry to identify proximity relationships
Fluorescence resonance energy transfer (FRET) to measure dynamic interactions in living cells
Cryo-electron microscopy of reconstituted complexes to visualize structural arrangements
Understanding these interactions provides insights into the assembly, stability, and functional regulation of the cytochrome c oxidase complex.
Post-translational modifications (PTMs) of COX6C can significantly alter its function within the oxidative phosphorylation system:
Common PTMs and their functional impacts:
Modification | Enzyme Responsible | Functional Impact |
---|---|---|
Phosphorylation | Various kinases | Alters complex assembly and activity |
Acetylation | Acetyltransferases | Modulates protein stability |
Ubiquitination | E3 ligases | Regulates protein turnover |
Oxidation | ROS exposure | Impairs function during oxidative stress |
To study these modifications:
Use mass spectrometry to identify and quantify PTMs on recombinant and native COX6C
Create site-specific mutants that mimic or prevent specific modifications
Perform functional assays (oxygen consumption, ATP production) with modified proteins
Analyze the impact of cellular stressors on COX6C modification patterns
Research indicates that altered post-translational modifications of COX subunits may contribute to mitochondrial dysfunction observed in cancer and neurodegenerative diseases.
Solution: Express as a fusion protein with solubility-enhancing tags (MBP, SUMO, or Thioredoxin)
Alternative: Include mild detergents (0.1% DDM or CHAPS) during extraction
Verification: Test multiple detergents at various concentrations to optimize solubilization
Solution: Lower induction temperature (16°C) and IPTG concentration (0.1 mM)
Alternative: Develop refolding protocols using gradual dialysis against decreasing urea or guanidine-HCl
Verification: Monitor protein folding using tryptophan fluorescence during refolding
Solution: Add protease inhibitor cocktail during all purification steps
Alternative: Express in protease-deficient bacterial strains
Verification: Perform Western blot analysis with anti-tag antibodies to detect degradation products
Solution: Optimize codon usage for the expression host
Alternative: Try different expression vectors with stronger or inducible promoters
Verification: Conduct time-course expression analysis to determine optimal harvest time
Activity loss during purification and storage can significantly impact research outcomes. Systematic troubleshooting should include:
During purification:
Monitor activity at each purification step using cytochrome c oxidation assays
Include stabilizing agents (10% glycerol, 1 mM DTT, 0.1% detergent) in all buffers
Keep samples on ice and minimize purification time
Avoid harsh elution conditions; use imidazole gradient elution for His-tagged proteins
During storage:
Store at -80°C in small aliquots to prevent freeze-thaw cycles
Include cryoprotectants (15-20% glycerol or sucrose)
Add reducing agents (1-5 mM DTT or β-mercaptoethanol) to prevent oxidation
Prepare protein at concentrations above 0.5 mg/mL to prevent adsorption to tubes
Activity recovery strategies:
Dialyze against fresh buffer containing cofactors
Remove potential inhibitors through size exclusion chromatography
Add lipids or detergent micelles to stabilize hydrophobic regions
Perform mild refolding by dialysis against decreasing concentrations of denaturing agents
Essential experimental controls:
Control Type | Purpose | Implementation |
---|---|---|
Wild-type recombinant COX6C | Baseline function | Express and purify under identical conditions |
Catalytically inactive mutant | Negative control | Introduce mutations in critical residues |
Empty vector | Background activity | Transfect cells with expression vector lacking COX6C |
Isogenic cell lines | Genetic background control | Use CRISPR to generate COX6C knockout before complementation |
Restoration of phenotype | Causality verification | Rescue experiments with wild-type protein |
Critical measurements:
Oxygen consumption rate (OCR) in basal and maximal respiration conditions
ATP synthesis rate in isolated mitochondria
Mitochondrial membrane potential using potentiometric dyes
Mitochondrial morphology using fluorescence microscopy and electron microscopy
Recent research has demonstrated that COX6C knockdown significantly decreases OCR in basal respiration, maximal respiration, and ATP turnover while increasing ROS production . These parameters should be measured when testing COX6C variants.
Studying the incorporation of recombinant COX6C into cytochrome c oxidase requires sophisticated analytical approaches:
In vitro reconstitution:
Isolate native cytochrome c oxidase complex lacking COX6C
Incubate with recombinant COX6C under physiological conditions
Analyze complex assembly using blue native polyacrylamide gel electrophoresis (BN-PAGE)
Perform activity assays before and after reconstitution to assess functional recovery
Cellular incorporation:
Express tagged recombinant COX6C in COX6C-depleted cells
Isolate mitochondria and solubilize with mild detergents
Perform immunoprecipitation with antibodies against other complex IV subunits
Analyze co-precipitated proteins by Western blotting and mass spectrometry
Real-time monitoring:
Generate fluorescently tagged COX6C variants
Use live-cell imaging to track incorporation into mitochondria
Perform fluorescence recovery after photobleaching (FRAP) to assess dynamics
Correlate incorporation with restoration of mitochondrial function
Distinguishing direct from indirect effects requires carefully designed experiments:
Immediate vs. delayed effects:
Use inducible expression or degradation systems for temporal control
Monitor mitochondrial parameters at multiple time points after COX6C manipulation
Early changes (minutes to hours) suggest direct effects, while later changes (days) may be adaptive responses
Specific rescue experiments:
Identify potential downstream effectors through proteomics and transcriptomics
Manipulate these effectors independently of COX6C
Determine if specific phenotypes can be rescued without restoring COX6C function
Molecular pathway analysis:
Use specific inhibitors of signaling pathways activated by mitochondrial dysfunction
Measure activation of AMPK and other energy-sensing pathways
Correlate pathway activation with specific mitochondrial defects
Research has shown that COX6C knockdown activates the AMPK pathway through ROS accumulation, leading to abnormalities in spindle formation and chromosome segregation . Using AMPK inhibitors can help differentiate between direct effects on oxidative phosphorylation and indirect effects through signaling pathways.
Computational methods offer powerful approaches for predicting how mutations or modifications might affect COX6C function:
Structural prediction and analysis:
Homology modeling based on related structures
Molecular dynamics simulations to assess structural stability
Docking studies with interaction partners, similar to those performed with allyl isothiocyanate (AITC) and cytochrome c oxidase subunits
Identification of critical binding residues and potential hydrogen bonds
Evolutionary analysis:
Multiple sequence alignment across species to identify conserved residues
Calculation of evolutionary rate to identify functional constraints
Coevolution analysis to identify residues that evolve together, suggesting functional linkage
Prediction of potentially damaging versus neutral variants
Systems biology approaches:
Network analysis to predict effects on related mitochondrial pathways
Flux balance analysis to model impacts on cellular metabolism
Integration of transcriptomic, proteomic, and metabolomic data
Machine learning models trained on known mitochondrial disease mutations
These computational predictions should always be validated experimentally, but they provide valuable guidance for experimental design and interpretation.